Matinas BioPharma Stock (MTNB)
Track Matinas BioPharma stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
MTNB
Matinas BioPharma
healthcare
$0.82
▼ -0.07 (-8.75%) past year
Market Cap
$4.66M
P/E Ratio
—
1Y Return
-8.75%
EPS (TTM)
-$2.02
Read the latest TheStreet Pro articles mentioning Matinas BioPharma, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning MTNB yet.
Daily Diary Mentions
0 mentionsNo diary mentions for MTNB yet.